Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Zohran Mamdani
New York State Politics
NATO
Heatwaves
Donald Trump
Social Media
Artificial Intelligence
Republican Party
Senate
Democratic Party
Gaming
World Cup
hastingsstargazette.com image

News from hastingsstargazette.com

If you want to know if hastingsstargazette.com is credible or reliable, look no further. We rank hastingsstargazette.com as High factuality. Find out more about our methodology here.

Information about hastingsstargazette.com

Where is hastingsstargazette.com located?hastingsstargazette.com's Website

Media Bias Ratings

Average Bias Rating:
Center
Center
byMedia Bias/Fact Check
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top hastingsstargazette.com News

US Supreme Court upholds ban on gender-affirming care for minors
Transgender · United States

US Supreme Court upholds ban on gender-affirming care for minors

40% Center coverage: 372 sources
See the Story
New clinical trial aims to prevent relapse in patients with DLBCL
West Virginia · West Virginia

New clinical trial aims to prevent relapse in patients with DLBCL

77% Center coverage: 79 sources
(BPT) - For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that one in three will see their cancer return…See the Story
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
Novo Nordisk · Denmark

Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects

76% Center coverage: 33 sources
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and other outcome results, including blood sugar levels, were positive. The company had previously announced top-line results for the 68-week studies, which found that CagriSema led to nearly 23% weight loss for overweight or obese adults, while overweight type 2 diabetics lost nearly 16% of their weight. Those results, however, disappointed investors, sending Novo's shares lower. The company last month ousted its CEO Lars Fruergaard Jorgensen.See the Story

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

100% Center coverage: 15 sources
Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1sDiabetes · HillsboroSee the Story

From Grit to Glory: Rockford Hosts Illinois' First IRONMAN, Cementing Its Role on the National Sports Stage

100% Center coverage: 11 sources
The sold-out IRONMAN 70.3 marks a multi-year partnership and a $25M economic win for RockfordTourism · RockfordSee the Story

Enhanced Detection of Diabetes Mellitus Using Novel Ensemble Feature Engineering Approach and Machine Learning Model

78% Center coverage: 27 sources
Diabetes is a persistent health condition led by insufficient use or inappropriate use of insulin in the body. If left undetected, it can lead to further complications involving organ damage such as heart, lungs, and eyes. Timely detection of diabetes helps obtain the right medication, diet, and exercise plan to lead a healthy life. ML approach has been utilized to obtain rapid and reliable diabetes detection, however, existing approaches suffer…Diabetes · MinnesotaSee the Story

Smart Insulin Tech Helps Pregnant Women with Type 1 Diabetes Maintain Target Blood Glucose Levels

76% Center coverage: 25 sources
Hybrid closed-loop technology effectively helped women stay in target glucose range for longer compared to standard of careDiabetes · CanadaSee the Story

Studies show promising results for individuals with type 2 diabetes and young children with type 1 diabetes on MiniMed™ 780G system

76% Center coverage: 26 sources
Data supports the potential of future indication expansion for the MiniMed™ 780G system. LENNY trial results published in Lancet Diabetes & Endocrinology.Minnesota · MinnesotaSee the Story

Stem Cell-Derived Islet Therapies Shown to Reduce the Need for Injectable Insulin

94% Center coverage: 34 sources
Breakthrough Studies Demonstrate Stem Cell-Based Technologies as a Potential Alternative Treatment for Type 1 DiabetesDiabetes · United StatesSee the Story

NexPoint Capital, Inc. Announces Tender Offer for Common Stock

76% Center coverage: 25 sources
DALLAS, June 20, 2025 /PRNewswire/ -- NexPoint Capital, Inc. (the "Company"), a non-traded publicly registered business development company sponsored and managed by NexPoint Advisors, L.P., today announced the expiration and final results for its tender offer (the "Tender Offer") for…Dallas, Texas · DallasSee the Story

Comerica Bank and Kalamazoo Growlers Summer Food Drive Returns to Increase Food Security in Community - Comerica (NYSE:CMA)

88% Center coverage: 17 sources
Donations to benefit South Michigan Food Bank; Public can claim free Growlers tickets and prizes DETROIT, June 20, 2025 /PRNewswire/ -- The fourth annual Comerica Bank-Kalamazoo Growlers Summer Food Drive returns Friday, June 20, to benefit the South Michigan Food Bank (SMFB). The public is encouraged to visit local participating Comerica banking centers in the Kalamazoo and Battle Creek region to drop off nonperishable food items. The summer f…Kalamazoo · KalamazooSee the Story

Breaking News Topics Related to hastingsstargazette.com

United States icon

United States

News
For You
SearchBlindspotLocal